| 摘要 |
<p>The invention relates to the use of an EBV membrane antigen GP350 or derivative thereof in combination with a suitable adjuvant in the manufacture of a vaccine for the prevention of infectious mononucleosis (IM), and to vaccine compositions suitable for prevention of IM.</p> |
